Schwartz Awarded Top ISOPP Honor
Rowena "Moe Schwartz, PharmD, associate professor of pharmacy practice within the James L. Winkle College of Pharmacy and pharmacist for the University of Cincinnati (UC) Cancer Institutes Phase I Experimental Therapeutics Program, received the Helen McKinnon Award at the 2018 International Society of Oncology Practitioners (ISOPP) Annual General Meeting April 12, 2018.
This award was created to honor Helen McKinnon who was instrumental in the formation of ISOPP and is given to those who promote and enhance oncology pharmacy practice worldwide in order to improve cancer patient care.
Schwartz, who joined the Winkle College of Pharmacy in 2016, teaches oncology pharmacy therapeutics and practice and works with students during their advanced pharmacy practice experiences. Additionally, she works as part of the UC Medical Centers oncology pharmacy team at the UC Health Barrett Cancer Center patient care facility in ambulatory oncology.
"This is a pretty incredible accomplishment. (Dr. Schwartz) is a huge asset to our clinics, says Trisha Wise-Draper, PhD, assistant professor of medicine in the Division of Hematology Oncology and medical director of the UC Cancer Institutes Clinical Trials Office.
Tags
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
Ohio nurses weigh in on proposed federal loan rule
December 12, 2025
Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.